The Global Tissue and Organ Transplantation Market to Witness Significant Growth Owing to Rising Prevalence of Organ Failure Worldwide
Tissue and organ transplantation involves replacing a damaged or missing organ with a healthy organ from another person. It is a viable treatment option for organ failure and other serious health conditions. The increasing prevalence of liver failure, renal failure, heart failure and other organ diseases is primarily driving the need for transplantation procedures globally. According to statistics, around 114,000 transplants were performed worldwide in 2021.
The global tissue and organ transplantation market is estimated to be valued at USD 29.2 billion in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024-2030.

Key Takeaways
Key players operating in The Tissue And Organ Transplantation Market Size is Medtronic PLC, Zimmer Biomet, Novartis AG, Stryker Corporation, 21st Century Medicine, BiolifeSolutions, Inc.

Get more insight on Tissue and Organ Transplantation Market
https://www.ukwebwire.com/tiss....ue-and-organ-transpl